Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899866-18-000089
Filing Date
2018-05-11
Accepted
2018-05-11 16:10:22
Documents
1
Period of Report
2018-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152606936697401.html 4  
1 FORM 4 wf-form4_152606936697401.xml 4 3297
  Complete submission text file 0000899866-18-000089.txt   4649
Mailing Address 100 COLLEGE STREET NEW HAVEN CT 06510
Business Address 100 COLLEGE STREET NEW HAVEN CT 06510 2032722596
ALEXION PHARMACEUTICALS INC (Issuer) CIK: 0000899866 (see all company filings)

EIN.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INCYTE CORPORATION 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address
FRIEDMAN PAUL A (Reporting) CIK: 0001236927 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27756 | Film No.: 18826975